Agilent director receives 2,158-share stock award

Agilent Technologies director Mikael Dolsten received a stock award, increasing his holdings.

Accepted by SEC EDGAR 03/23/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Agilent Technologies director Mikael Dolsten received a stock award, increasing his holdings. He was granted 2,158 shares of Agilent common stock at a value of $111.75 per share as a fully vested award for non-employee directors. Following the grant, he directly holds 7,138.2100 shares of common stock. Dolsten elected to defer receipt of 1,079 of the granted shares, and an additional 7.182 shares were acquired and deferred through the company’s dividend reinvestment plan.

Insider Trade Summary

Grant/Award: 2,158 shares

Grant/Award 1 txn

Insider Dolsten Mikael

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,158	$111.75	$241K

Holdings After Transaction: Common Stock — 7,138.21 shares (Direct)

Footnotes (2)

1. F1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of 1,079 shares of common stock.
2. F2. 7.182 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Agilent (A) director Mikael Dolsten report in this Form 4?

Director Mikael Dolsten reported receiving a fully vested award of 2,158 shares of Agilent common stock. This is a compensation-related grant for a non-employee director, not an open-market stock purchase or sale.

How many Agilent (A) shares did Mikael Dolsten receive and at what value?

Mikael Dolsten received 2,158 shares of Agilent common stock valued at $111.75 per share. The award was fully vested upon grant as part of his compensation as a non-employee director of Agilent Technologies.

How many Agilent (A) shares does Mikael Dolsten hold after this transaction?

After the transaction, Mikael Dolsten directly holds 7,138.2100 shares of Agilent common stock. This figure reflects his position following the 2,158-share fully vested stock award reported in the Form 4 filing.

Did Mikael Dolsten buy or sell Agilent (A) shares on the market in this filing?

No, the filing shows a grant of 2,158 shares as director compensation, not a market trade. The transaction is classified as a grant or award acquisition rather than an open-market purchase or sale of Agilent shares.

What portion of Mikael Dolsten’s Agilent (A) stock award was deferred?

Mikael Dolsten elected to defer receipt of 1,079 of the 2,158 granted shares. He also deferred 7.182 additional shares that were acquired through Agilent’s dividend reinvestment plan, according to the filing’s footnotes.

Are the Agilent (A) director shares fully vested, and what does that mean?

Yes, the shares are fully vested upon grant, meaning Dolsten’s rights to them are not subject to future service or performance conditions. Vesting removes forfeiture risk, even though he elected to defer receipt of some shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dolsten Mikael

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CALIFORNIA 95051

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		A		2,158	A	$111.75(1)	7,138.21(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of 1,079 shares of common stock.

2. 7.182 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock.

	/s/ Shirley Qin, attorney-in-fact for Mr. Dolsten	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)